Cargando…

Evidence for classic complement activity in neuromyelitis optica

Abstract not available.

Detalles Bibliográficos
Autores principales:	Jones, Melina V., Fox-Talbot, Karen, Levy, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551770/ https://www.ncbi.nlm.nih.gov/pubmed/24569172 http://dx.doi.org/10.5414/NP300697

Ejemplares similares

Devic's neuromyelitis optica associated with active pulmonary tuberculosis, Tunisia
por: Zayet, S., et al.
Publicado: (2020)

Neuromyelitis Optica Spectrum Disorder Presenting with Pseudoathetosis
por: Seok, Hung Youl, et al.
Publicado: (2018)

Eculizumab in the treatment of neuromyelitis optica spectrum disorder
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica
por: Jones, Melina V., et al.
Publicado: (2018)

Nonscalpel myelopathy: Cervical myelopathy secondary to neuromyelitis optica
por: Patel, Mohit, et al.
Publicado: (2020)

Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica
por: Etemadifar, Masoud, et al.
Publicado: (2014)

Neuromyelitis Optica Spectrum Disorder in a Patient with Ankylosing Spondylitis
por: Jeong, Soo, et al.
Publicado: (2018)

Neuromyelitis Optica Spectrum Disorder with Vertical Gaze Palsy and Hypersomnolence
por: Mathew, Jomal, et al.
Publicado: (2019)

Subacute Myelopathy: Think Beyond Neuromyelitis Optica Spectrum Disorder
por: Kasinathan, Ananthanarayanan, et al.
Publicado: (2019)

Comment: Nonscalpel myelopathy: Cervical myelopathy secondary to neuromyelitis optica
por: Fustes, Otto Jesus Hernandez, et al.
Publicado: (2020)

Cortical Blindness: An Unusual Manifestation of Neuromyelitis Optica Spectrum Disorder
por: Reddy Nagireddy, Ram Bhupal, et al.
Publicado: (2022)

Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica
por: Jones, Melina V., et al.
Publicado: (2015)

Paraneoplastic Neuromyelitis Optica Associated with Lung Adenocarcinoma in a Young Woman
por: Baik, Kyoung Won, et al.
Publicado: (2018)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
por: Özçelik, Pınar, et al.
Publicado: (2017)

The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica
por: Verkman, Alan S., et al.
Publicado: (2018)

Response to ‘The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica’
por: Frigeri, Antonio, et al.
Publicado: (2018)

Improvement to baseline after plasma exchange in spinal attacks associated with neuromyelitis optica
por: Bonnan, Mickael, et al.
Publicado: (2015)

COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
por: Cabal-Herrera, Ana Maria, et al.
Publicado: (2021)

Recurrent hiccups in COVID-19 forme fruste of neuromyelitis optica spectrum disorder?
por: Shubhakaran, Khichar P.
Publicado: (2022)

Moyamoya disease presenting as thalamic infarction in a patient with neuromyelitis optica spectrum disorder
por: Zhang, Yin‐Xi, et al.
Publicado: (2019)

Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report
por: Khorvash, Fariborz, et al.
Publicado: (2016)

Seronegative neuromyelitis optica spectrum disorder in primary familial brain calcification with PDGFB variant
por: Biyajima, Masahiro, et al.
Publicado: (2022)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader, Simone, et al.
Publicado: (2011)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder
por: Hsu, Chia-Lun, et al.
Publicado: (2016)

Relapse After Cessation of Immunosuppressants in Seropositive Neuromyelitis Optica Spectrum Disorder With Long-Term Remission
por: Seok, Jin Myoung, et al.
Publicado: (2021)

Aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder with cholangiocarcinoma: Casual or causal association?
por: Fang, Wei, et al.
Publicado: (2022)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
por: Liu, Yiting, et al.
Publicado: (2016)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
por: Miyamoto, Katsuichi, et al.
Publicado: (2023)

Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders
por: Levy, Michael
Publicado: (2018)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

New Therapeutic Landscape in Neuromyelitis Optica
por: Tugizova, Madina, et al.
Publicado: (2021)

A Little-Known Brain Imaging Feature in Neuromyelitis Optica Spectrum Disorder: A Leukodystrophy-Like Pattern
por: Lee, Jun Seok, et al.
Publicado: (2019)

Molecular Pathogenesis of Neuromyelitis Optica
por: Bukhari, Wajih, et al.
Publicado: (2012)

B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rs1k7dfqcti6v5su87r6jr7092